BioImpacts ISSN: 2228-5652 ; eISSN: 2228-5660
Where biological impacts are presented for biomedical and pharmaceutical scientists - Integrative Researches for Translational Medicines.
The BioImpacts (BI) publishes timely, peer-reviewed papers on current topics important to biomedical/pharmaceutical scientists/researchers. Four quarterly issues cover a wide range of topics, including contemporary issues in biological (in vitro and in vivo) impacts of advanced and futuristic intervention at molecular, cellular and in vivo dimensions.
The journal's insights make it attractive platform for professional multidisciplinary scientists such as cellular and molecular biologists, pharmacologists, biomedical technologist, pharmaceutical scientists, biological chemists, experimental biologists, geneticists, neuroscientists, biochemists, physiologists, biomedical researchers, translational scientists and related clinicians.
Integrative research, translational science, translational medicine, applied science, molecular biology, cell biology, genomics and related omics technologies, systems biology, genetics, epigenetics, biomedicine, nanomedicine, molecular medicine, molecular therapy, gene and cell therapy, cell engineering, tissue engineering, biotechnology, nanotechnology, synthetic biology, human biology, human genomics and proteomics, molecular pharmacology, herbal medicine, nanobio sensing and detection, science communication, public perception of science, bioscience education, bioethics, molecular imaging, biosimulation, bioinformatics.
ISSN: 2228-5652 ; eISSN: 2228-5660
First Issue: March 2011
Impact factor: -
Immediacy index: -
Frequency: 4 issues per year, 6 issues since 2015
Publisher: Tabriz University of Medical Sciences